Medtronic's CRM unit "bucks trend", helping Q2 sales beat analyst expectations
This article was originally published in Clinica
Executive Summary
Medtronic saw its "sales momentum continue" during its second fiscal quarter, according to Morgan Stanley analyst David Lewis. The firm's Q2 revenues of $4.1 billion, up 2% year-on-year, beat his prediction of $4.02 billion and analyst consensus of $4.05 billion. Medtronic would have done even better had it not been for foreign exchange headwinds – sales grew 5% on a constant currency basis.